AccueilPodcastsThe Long Run with Luke TimmermanEp201: Jeremy Levin on Biotech in the BalanceThe Long Run with Luke TimmermanEp201: Jeremy Levin on Biotech in the Balance19 mai 2026 · 1 h 9 minLire l’épisodePartager à partir d’iciNotes de l’épisodeJeremy Levin, executive chair of Ovid Therapeutics, discusses his new book "Biotech in the Balance: Saving a Strategic Industry in an Age of Distrust."Tous les épisodes de The Long Run with Luke Timmerman